In:
Blood, American Society of Hematology, Vol. 126, No. 16 ( 2015-10-15), p. 1921-1924
Abstract:
CLL patients harboring mutated IGHV genes but neither 11q or 17p deletion experience durable remission after frontline FCR.
Type of Medium:
Online Resource
ISSN:
0006-4971
,
1528-0020
DOI:
10.1182/blood-2015-05-647925
Language:
English
Publisher:
American Society of Hematology
Publication Date:
2015
detail.hit.zdb_id:
1468538-3
detail.hit.zdb_id:
80069-7